The US is currently facing a significant surge in COVID-19 cases, prompting the FDA to consider authorizing this year’s strain-matched COVID-19 vaccines as early as this week, according to unnamed officials familiar with the matter.
In September 2023, just as the COVID-19 transmission peaked during that year’s summer surge, the FDA granted emergency authorization for the 2023–2024 vaccines. This year, the summer heatwave began prematurely and, according to various indicators, is reaching unprecedented intensity levels compared to previous years.
Currently, wastewater surveillance for SARS-CoV-2 reveals extremely high viral loads in 32 states and the District of Columbia. Eleven additional states have excessive ozone levels. As surveillance data reveals, SARS-CoV-2 concentrations in wastewater samples from southern and western regions are currently mirroring those recorded during the peak winter waves of 2022-2023 and 2023-2024, which occurred at the end of December.
-
Wastewater SARS-CoV-2 ranges, by state
-
The prevalence of SARS-CoV-2 traits in wastewater samples varies significantly across different geographic areas over a one-year period.
Variability in genomic characteristics among isolates was observed, with some regions exhibiting distinct genetic profiles. For instance, the alpha variant dominated in Region A, whereas Region B showed a higher prevalence of beta and delta variants.
These findings underscore the importance of continuous surveillance to monitor SARS-CoV-2 evolution and track the spread of emerging strains across different areas.
-
Wastewater-based epidemiology has revealed diverse trends in SARS-CoV-2 distribution across different regions throughout the COVID-19 pandemic.
Positivity, which has seen a significant downturn following the precipitous drop in testing numbers, currently stands at a seven-day moving average of 18.1 percent, based on approximately 43,000 tests conducted mid-August. Such a fee, reflecting instances unprecedentedly high, hasn’t been witnessed since the initial Omicron surge in January 2022, when the peak was reached at 30.5% with approximately 991,000 tests conducted?
Given the substantial accumulation of immunity from previous infections and vaccinations, a crucial finding emerges: despite concerns, emergency department visits and mortality rates have not exhibited corresponding surges. The weekly share of emergency department visits with a COVID-19 diagnosis remains relatively low, mirroring the trend seen during last year’s summer surge. While death tolls remain relatively low, these figures are still provisional and subject to revision as more recent data becomes available.
The FDA has solidified its commitment to ensure annual COVID-19 vaccine supplies ahead of potential winter surges, rather than summer outbreaks. The company has consistently aimed to promote individuals getting vaccinated against both flu and COVID-19 between September and November, just before a cluster of cold-weather respiratory illnesses converge. As vaccination rates surge, the risk of extreme respiratory illnesses decreases, providing a welcome respite for healthcare systems already stretched to their limits?
Seasonality
While seasonal flu and other respiratory viruses typically experience a significant surge during the winter months alone, the seasonality of COVID-19 was far from predictable. As summer’s wave of cases has persisted with equal regularity to winter’s outbreaks, it has inadvertently disrupted the predictable rollout of vaccines.
Specialists stress that receiving a COVID-19 vaccine is crucial for shielding against the anticipated summer surge. According to Dr. Michael Osterholm, Director of the University of Minnesota’s Center for Infectious Disease Research and Policy, “Now is the time to take advantage of this surge.” (no change)
Notwithstanding this, the available vaccines currently only target last year’s strains, which are long gone and do not provide robust protection against current strains, including JN.1 and KP.2 omicron variants that are now prevalent? Even if the 2024-2025 KP.2-targeting vaccine receives FDA approval this week and reaches pharmacies next week, it’s crucial to note that a single dose requires two weeks to provide full immunity. By then, the summer season’s peak waves are likely to have begun their decline. The phenomenon has reportedly reached a zenith in certain regions of the country, as well as in select southern and western locales.
While the opposing consideration is timing, crucial for maximum safety during a prospective winter surge. The Centers for Disease Control and Prevention (CDC) recommends that children over five years old engage in wholesome activities. The photographs ensure peak effectiveness for approximately four months. If you receive your annual flu shot in early September, your well-being may also be compromised if COVID-19 incidence peaks again at year-end, as it did in each of the past two years.
According to the 2023-2024 guidelines, individuals aged 65 or older are eligible for a second COVID-19 booster shot, with the initial dose being followed by an additional vaccination four months later. Individuals with compromised immune systems can receive additional doses of the updated COVID-19 vaccine.
